最終更新日：2024/08/02

(pharmacology) A human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.

正解を見る

sifalimumab

問題を編集する

元となった辞書の項目

sifalimumab

noun

(pharmacology) A human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.

Sifalimumab is a new drug that shows promise in treating autoimmune diseases.

意味（1）

(pharmacology) A human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.